Medicinal Products

Nuvaxovid, cjepivo protiv COVID-19 (rekombinantno, adjuvantirano)

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Nuvaxovid, cjepivo protiv COVID-19 (rekombinantno, adjuvantirano)
Active Substance rekombinantni protein ĊĦiljka virusa SARS-CoV-2
Prescription na recept
Type of prescription neponovljivi recept
Distribution u ljekarni
ATC Code J07BN04
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Back